Imatinib is a medication used to treat cancer.

The global Imatinib Mesylate Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Imatinib Mesylate Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Imatinib Mesylate Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Imatinib Mesylate Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Imatinib Mesylate Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
100mg
400mg

Segment by Application
Hospital
Pharmacy